US Aligns with Japan, Canada, Norway and Others at the World’s Largest Conference on Dementia Researchers for Alzheimer’s Association International Conference 2026: Here’s Everything You Need to Know Now

Written By: Minal Aditi Lakra

Minal Aditi Lakra

I graduated with a degree in Finance from the University of Calcutta and further strengthened my financial expertise by pursuing both the Chartered Accountancy (CA) and Certified Financial Planner (CFP) programs. Over the past decade, I have dedicated myself to building a career aligned with my long-term professional aspirations, combining analytical thinking with strategic communication. Currently, I work as a Public Relations Strategist at Travel And Tour World (TTW), a global travel media platform that connects industry leaders with travelers worldwide. My role involves translating the vision, insights, and innovations of tourism stakeholders—including governments, tourism boards, airlines, hospitality brands, and event organizers—into compelling stories that inform, inspire, and influence global travel audiences. Through strategic storytelling and media engagement, I help bridge the gap between industry leadership and evolving traveler expectations.

See Full Bio

July 4, 2026 06:54 GMT+5:30

Image generated with Ai

London is preparing to welcome one of the world’s most influential scientific gatherings as the Alzheimer’s Association International Conference (AAIC) 2026 arrives at ExCeL London from 12 to 15 July 2026, with pre-conference educational workshops taking place on 10 and 11 July. Bringing together thousands of researchers, clinicians, healthcare professionals, biotechnology companies and policymakers, the conference is expected to reinforce the United Kingdom’s standing as a leading destination for international medical meetings while generating significant benefits for business travel, hospitality and the wider visitor economy.

Recognised as the largest international conference dedicated to Alzheimer’s disease and other dementias, AAIC has become a key platform where groundbreaking research is unveiled, clinical advances are debated and global collaborations are forged. Rather than serving as a conventional scientific meeting, the conference acts as an international forum where academia, healthcare providers, pharmaceutical innovators and public health organisations collectively shape the future of dementia diagnosis, treatment and prevention.

A Strategic Event for London’s MICE Industry

Hosting AAIC 2026 further strengthens London’s reputation as one of Europe’s premier destinations for meetings, incentives, conferences and exhibitions (MICE). ExCeL London has become synonymous with major international congresses spanning healthcare, technology, sustainability, finance and advanced manufacturing, attracting delegates from across every continent.

The arrival of thousands of international participants is expected to stimulate demand across London’s hospitality sector, including hotels, restaurants, local transport services and cultural attractions. International conferences of this scale typically encourage delegates to extend their visits, creating additional opportunities for leisure tourism before and after the scientific programme.

The event also highlights the UK’s continued attractiveness for high-value knowledge exchange, positioning London as an important meeting point for global healthcare innovation.

Scientific Collaboration Takes Centre Stage

AAIC 2026 will feature an extensive scientific programme covering the latest developments in Alzheimer’s disease and dementia research. The conference will bring together internationally recognised experts representing universities, hospitals, biotechnology companies and research institutes.

Confirmed plenary speakers include Ryan Watts of Denali Therapeutics, Suzanne E. Schindler of Washington University in St. Louis, Daisy Acosta from the Dominican Republic, Takaomi C. Saido of Japan’s RIKEN Center for Brain Science, Betty Tijms of Amsterdam UMC, Zahinoor Ismail representing institutions in Canada and the United Kingdom, and Dag Aarsland of King’s College London and Stavanger University Hospital.

Their participation reflects the increasingly international nature of dementia research, with expertise spanning North America, Europe, Asia and the Caribbean.

International Participation Reflects Global Health Priorities

Alzheimer’s disease remains one of the world’s fastest-growing public health challenges, making international collaboration increasingly essential. AAIC regularly attracts participants from more than 100 countries, creating an environment where researchers exchange scientific evidence, establish multinational collaborations and accelerate clinical innovation.

The conference is expected to welcome neurologists, neuroscientists, geriatricians, psychiatrists, public health experts, clinical researchers, healthcare professionals, government representatives, pharmaceutical companies, biotechnology firms, diagnostics specialists and advocacy organisations.

This broad representation enables discussions that extend beyond laboratory research to include healthcare policy, early diagnosis, emerging therapeutics, digital health technologies and strategies to improve dementia care worldwide.

Industry Innovation and Commercial Opportunities

Beyond the scientific sessions, AAIC also provides an important commercial platform for organisations developing new diagnostics, treatments and healthcare technologies.

Companies such as Roche Diagnostics have already confirmed their participation, while the exhibition is expected to feature pharmaceutical manufacturers, biotechnology innovators, medical device companies, diagnostic solution providers and research organisations showcasing the latest advances in dementia care.

For industry participants, the conference offers valuable opportunities to establish partnerships, explore investment opportunities and engage directly with leading researchers and clinicians.

Benefits for Tourism and the Visitor Economy

Major international medical congresses have become increasingly important drivers of business tourism. Delegates attending AAIC are likely to utilise London’s extensive hotel inventory, dine at local restaurants, visit museums and cultural attractions and make use of the capital’s comprehensive public transport network.

The conference also supports employment across hospitality, transport, event management, catering and tourism services while contributing to London’s reputation as a year-round destination for international business events.

As governments around the world continue investing in life sciences and medical research, conferences such as AAIC generate long-term economic value that extends well beyond the duration of the event itself.

Looking Ahead

As ExCeL London prepares to host the Alzheimer’s Association International Conference 2026, the event represents far more than a gathering of scientists. It demonstrates how global medical conferences increasingly serve as catalysts for international collaboration, knowledge exchange and business travel.

For London and the wider United Kingdom, AAIC 2026 reinforces the country’s ability to attract high-profile international congresses that support tourism, stimulate the visitor economy and strengthen its position within the global MICE industry. At the same time, the conference offers the international dementia community an opportunity to accelerate research that could shape future healthcare outcomes for millions of people worldwide.